RIPK3 and viral infectious disease: Our model suggests that the OASL–RIPK3 interaction enhances the formation of the RIPK3 amyloid-like fibril signalling complex, which prolongs RIPK3 activation and drives high levels of MLKL phosphorylation, ultimately inducing robust necroptosis during virus infection.